Latest Breaking News On - Sorbitol dehydrogenase deficiency - Page 1 : vimarsana.com

StockWatch: Biogen s Q4 Results Disappoint Analysts

StockWatch: Biogen s Q4 Results Disappoint Analysts
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

United statesCarter gould barclaysBrian abrahamsJay olson oppenheimerMylesr minterFadia needhamSumant kulkarni canaccord genuityEvan seigermanBrianp skorneyWilliam blairMohit bansalMichaelj yeeChristophera viehbacherGeoff meachamChristopher raymond piper sandlerSarah schram

Live by the SORD: Applied Therapeutics looks to rare disease NDA

Based on positive phase III study data, Applied Therapeutics Inc. plans to take its CNS-penetrant aldose reductase inhibitor to the U.S. FDA to talk about an NDA for treating the rare disease sorbitol dehydrogenase (SORD) deficiency. SORD, a hereditary axonal neuropathy created by sorbitol dehydrogenase gene mutations, affects about 3,300 people in the U.S. and about 4,000 in Europe, according to Applied Therapeutics.

Therapeutics incApplied therapeuticsApplied therapeutics incAt 007Sorbitol dehydrogenase deficiencyRare diseaseNeurology psychiatricCharcot marie tooth diseaseDistal hereditary motor neuropathy

Applied Therapeutics: Update Following Failure In Diabetic Cardiomyopathy (Downgrade)

Applied Therapeutics: Update Following Failure In Diabetic Cardiomyopathy (Downgrade)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesAndrzej rostekAdvanz pharmaSorbitol dehydrogenase deficiencyRare pediatric disease designation